Pietro Barilla Children's Hospital, Pediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Via Gramsci 14, 43126, Parma, Italy.
Università degli Studi di Milano, Milan, Italy.
Ital J Pediatr. 2022 Mar 9;48(1):42. doi: 10.1186/s13052-022-01233-6.
Two sequelae of pediatric COVID-19 have been identified, the multisystem inflammatory syndrome in children (MIS-C) and the long COVID. Long COVID is much less precisely defined and includes all the persistent or new clinical manifestations evidenced in subjects previously infected by SARS-CoV-2 beyond the period of the acute infection and that cannot be explained by an alternative diagnosis. In this Intersociety Consensus, present knowledge on pediatric long COVID as well as how to identify and manage children with long COVID are discussed.
Although the true prevalence of long COVID in pediatrics is not exactly determined, it seems appropriate to recommend evaluating the presence of symptoms suggestive of long COVID near the end of the acute phase of the disease, between 4 and 12 weeks from this. Long COVID in children and adolescents should be suspected in presence of persistent headache and fatigue, sleep disturbance, difficulty in concentrating, abdominal pain, myalgia or arthralgia. Persistent chest pain, stomach pain, diarrhea, heart palpitations, and skin lesions should be considered as possible symptoms of long COVID. It is recommended that the primary care pediatrician visits all subjects with a suspected or a proven diagnosis of SARS-CoV-2 infection after 4 weeks to check for the presence of symptoms of previously unknown disease. In any case, a further check-up by the primary care pediatrician should be scheduled 3 months after the diagnosis of SARS-CoV-2 infection to confirm normality or to address emerging problems. The subjects who present symptoms of any organic problem must undergo a thorough evaluation of the same, with a possible request for clinical, laboratory and / or radiological in-depth analysis in case of need. Children and adolescents with clear symptoms of mental stress will need to be followed up by existing local services for problems of this type.
Pediatric long COVID is a relevant problem that involve a considerable proportion of children and adolescents. Prognosis of these cases is generally good as in most of them symptoms disappear spontaneously. The few children with significant medical problems should be early identified after the acute phase of the infection and adequately managed to assure complete resolution. A relevant psychological support for all the children during COVID-19 pandemic must be organized by health authorities and government that have to treat this as a public health issue.
小儿 COVID-19 有两种后遗症,即儿童多系统炎症综合征(MIS-C)和长 COVID。长 COVID 的定义不太准确,包括 SARS-CoV-2 感染后超过急性感染期且无法用其他诊断解释的所有持续或新的临床症状。在本次多学会共识中,讨论了儿科长 COVID 的现有知识,以及如何识别和管理长 COVID 患儿。
尽管小儿长 COVID 的真实患病率尚不确定,但似乎建议在急性感染期结束后约 4 至 12 周,临近疾病末期时评估存在长 COVID 症状。怀疑患有儿童和青少年长 COVID 时,应考虑持续性头痛和疲劳、睡眠障碍、注意力集中困难、腹痛、肌痛或关节痛。持续性胸痛、胃痛、腹泻、心悸和皮疹应被视为长 COVID 的可能症状。建议初级保健儿科医生在急性 SARS-CoV-2 感染后 4 周对所有疑似或确诊 SARS-CoV-2 感染的患儿进行就诊,以检查是否存在以前未知的疾病症状。在任何情况下,在 SARS-CoV-2 感染诊断后 3 个月,应安排初级保健儿科医生进行进一步检查,以确认正常或解决新出现的问题。出现任何器官问题症状的患儿必须对其进行彻底评估,并在需要时可能要求进行临床、实验室和/或影像学深入分析。有明显精神压力症状的患儿和青少年需要由现有地方服务机构跟进此类问题。
小儿长 COVID 是一个相关的问题,涉及相当比例的儿童和青少年。这些患儿的预后通常良好,因为大多数患儿的症状会自行消失。少数有明显医疗问题的患儿应在感染的急性期后尽早识别,并进行适当管理,以确保完全缓解。卫生当局和政府必须组织对所有 COVID-19 患儿的相关心理支持,并将其作为一个公共卫生问题进行处理。